Publications by authors named "Frank Giles"

Claim this Profile
G
Grove-First: A Generalizable Framework to Evaluate Translational Solutions to Citrus Greening and Other Perennial Crop Diseases.
Michelle L Heck, Nicholas Larson, Guilherme Locatelli, Ellen Cochrane, Samuel Coradetti, Frank Giles

Plant Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilars: Are They Really Safe?
June M McKoy, Frank J Giles

Cancer Treat Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review.
Young Kwang Chae, Lauren Chiec, Scott K Adney, Josh Waitzman, Ricardo Costa, Frank Giles

Oncotarget· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.
Juan Luis Steegmann, Dolors Colomer, Maria-Teresa Gómez-Casares, Valentín García-Gutiérrez, Guillermo Ortí, Frank Giles

J Cancer Res Clin Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.
Juan Luis Steegmann, Dolors Colomer, Maria-Teresa Gómez-Casares, Valentín García-Gutiérrez, Guillermo Ortí, Frank Giles

J Cancer Res Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia.
Sieghart Sopper, Satu Mustjoki, Deborah White, Timothy Hughes, Peter Valent, Frank Giles

J Clin Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia.
Ophelia Q P Yin, Frank J Giles, Michele Baccarani, Philipp le Coutre, Ovidiu Chiparus

Cancer Chemother Pharmacol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elacytarabine--lipid vector technology overcoming drug resistance in acute myeloid leukemia.
Aine Carol Burke, Frank James Giles

Expert Opin Investig Drugs· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laromustine (cloretazine).
Norbert Vey, Frank Giles

Expert Opin Pharmacother· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
David J Adams, Marit L Sandvold, Finn Myhren, Tove F Jacobsen, Frank Giles

Leuk Lymphoma· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors.
Mark Levis, Patrick Brown, B Douglas Smith, Adam Stine, Rosalyn Pham, Frank Giles

Blood· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel agents in acute myeloid leukemia.
Ahmed Aribi, Farhad Ravandi, Frank Giles

Cancer J· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloretazine for the treatment of acute myeloid leukemia.
Norbert Vey, Frank Giles

Expert Rev Anticancer Ther· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis